Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dan Shilo

Vascular & Interventional Radiology New York, NY Medical Doctor

NPI 1912268780 CMS profile 4477020

1468 Madison Ave, New York, NY 10029

Open in the dashboard

General payments

$25,462

65 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$19,949 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Dan Shilo of New York, NY is reported in the CMS Open Payments database as having received $25,462 across 65 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $19,949 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,560 15
2024 General $4,432 17
2023 General $232 3
2022 General $805 15
2021 General $1,480 5
2019 General $953 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dan Shilo
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Dan Shilo were reported at $17,560. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Dan Shilo Vascular & Interventional Radiology median Middle half National median
2019 $953 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $1,480 $280 $99–$866 $132
2022 $805 $433 $137–$1,497 $149
2023 $232 $506 $152–$2,019 $160
2024 $4,432 $556 $175–$1,930 $164
2025 $17,560 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Siemens Medical Solutions USA, Inc. $19,801 26 payments
  2. Penumbra, Inc. $2,062 9 payments
  3. Boston Scientific Corporation $1,817 5 payments
  4. Inari Medical, Inc. $784 13 payments
  5. Teleflex LLC $400 1 payment
  6. Imperative Care, INc $199 2 payments
  7. Bard Peripheral Vascular, Inc. $176 3 payments
  8. Ethicon US, LLC $111 1 payment
  9. Argon Medical Devices, Inc. $49 2 payments
  10. Terumo Medical Corporation $31 1 payment
  11. Other $33 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $14,764 15 payments
  2. Consulting Fee $6,400 5 payments
  3. Food and Beverage $3,098 44 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,200 1 payment
Products named General payments · program years 2019–2025
  1. Artis icono floor $1,869 11 payments
  2. Indigo System $1,564 4 payments
  3. FLOWTRIEVER CATHETER, S $647 12 payments
  4. CT THROMBECTOMY SYSTEM KIT $647 12 payments
  5. Indigo $389 3 payments
  6. Penumbra Ruby Coil $205 2 payments
  7. PRODIGY CATHETER $199 2 payments
  8. VENOVO $160 2 payments
  9. FlowTriever $137 1 payment
  10. ClotTriever $137 1 payment
  11. Other $516 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$54,824

Of which drugs: $612

Medicare patients

193

Average age 74

Services billed

4,806

97 women, 96 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 58%
Arthritis 52%
Ischemic heart disease 50%
Chronic kidney disease 46%
Heart failure 41%
Atrial fibrillation 31%
Cancer 30%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 46 4,393 $459

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

65 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record